(Q66034440)
Statements
An Open-Label Randomized Phase III Study Comparing Xeloda (Capecitabine) With IV Bolus 5-Fluorouracil in Combination With Low-Dose Leucovorin as Adjuvant Chemotherapy in Patients Who Underwent Surgery for Dukes C Colon Cancer (English)
0 references
November 1998
0 references
April 2004
0 references
1,987
0 references
18 year
0 references
75 year
0 references